Howard W. Robin
Overview
Howard W. Robin received an average of $7M in total compensation, including $864K in salary, at Nektar Therapeutics from 2007 to 2021.
2021Nektar TherapeuticsPresident and Chief Executive Officer
2020Nektar TherapeuticsPresident and Chief Executive Officer
2019Nektar TherapeuticsPresident and Chief Executive Officer
2018Nektar TherapeuticsPresident and Chief Executive Officer
2017Nektar TherapeuticsPresident and Chief Executive Officer
2016Nektar TherapeuticsPresident and Chief Executive Officer
2015Nektar TherapeuticsPresident and Chief Executive Officer
2014Nektar TherapeuticsPresident and Chief Executive Officer
2013Nektar TherapeuticsPresident and Chief Executive Officer
2012Nektar TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 29, 2022, April 30, 2021, April 30, 2019, April 30, 2018, April 29, 2016, April 30, 2015, April 30, 2014, April 30, 2013, April 30, 2012, April 29, 2011, and April 29, 2009.
Related executives
We found 20 more executives who work or worked at Nektar Therapeutics.
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
Jonathan Zalevsky
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
John Northcott
Nektar Therapeutics
Senior Vice President and Chief Commercial Officer
Mark Wilson
Nektar Therapeutics
General Counsel
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer
John Nicholson
Nektar Therapeutics